pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

Drug Discovery World

OCTOBER 16, 2023

Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

MARCH 9, 2021

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment that could be effective against emerging COVID-19 variants.

Antibody 98

Antibody Life Science Scientist Vaccination 98

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. It’s been eventful 12-month period for the UK biotech guru Clive Dix, who has just seen his company C4X Discovery clinch a major inflammatory diseases deal with Sanofi.

Vaccination 86

Vaccination Vaccine Life Science Antibody 86

XTalks

OCTOBER 4, 2023

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Linking pharma with patients.

Clinical Trials 89

Clinical Trials Clinical Trials Trials Clinical Research 89

Drug Discovery World

OCTOBER 7, 2022

Earlier this year, Cancer Research UK (CRUK) launched its innovation engine, Cancer Research Horizons, to streamline drug discovery through the combination of its commercial and therapeutics teams. RA: Could you tell us about Cancer Research Horizons? . This is about changing how we operate. Hamish Ryder.

HR 52

HR Research Drugs Development 52

XTalks

SEPTEMBER 5, 2023

Xtalks spoke with Maria Reyes Boceta-Muñoz, Clinical Operations Head of Development R&D at GlaxoSmithKline in Spain, Portugal & Israel, to understand the current vaccine development climate and where the sector is headed. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

XTalks

MARCH 28, 2024

The FDA’s approval of Duvyzat for DMD, based on our robust and successful clinical development program, reflects Italfarmaco’s commitment to providing a safe and proven-effective therapy that can have a meaningful impact for people living with DMD,” said Paolo Bettica, MD, PhD, chief medical officer at Italfarmaco Group in a press release.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical Data Pipeline for Data Review and Analyses.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

Pharmaceutical Technology

MAY 26, 2023

After raising $125m in 2021 to redevelop the facility, more recently Touchlight secured an additional $17.3m (£14m) from the UK government’s Life Sciences Innovative Manufacturing Fund to accelerate its expansion plans and scale-up equipment. Rapid production will potentially enable researchers to overcome an industry bottleneck.

DNA 130

DNA Manufacturing Gene Therapy Gene 130

pharmaphorum

APRIL 7, 2021

While the Darzalex revenues are due to fall this year because of Janssen’s interpretation of the agreement between the two companies, there are also other revenue streams. With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. Role models.

Antibody 65

Antibody Life Science Development Regulation 65

XTalks

AUGUST 18, 2021

“I think that the pandemic has drawn much attention to some of the threats that have been posed by emerging infections,” says Brian Murphy, MD, MPH, FIDSA, Vice President of the Medical Department for global contract research organization (CRO) Medpace. And again, reminded us all of the importance of investing in public health.”.

Development 105

Development Bacteria Drugs Vaccination 105

The Pharma Data

DECEMBER 17, 2020

Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Prior to Fulcrum, Cadavid held several leadership positions at Biogen, including Senior Medical Director of the multiple sclerosis clinical development group.

Development 52

Development Gene Therapy Engineer Life Science 52

Drug Discovery World

OCTOBER 4, 2022

Taking place at the ExCel in London from 4-5 October, ELRIG Drug Discovery 2022 is set to provide visitors with access to the latest trends, technologies and expertise driving the life sciences sector. . Other sessions will explore the benefits of automation and give insight into how it can help researchers and labs gain value. .

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

Delveinsight

AUGUST 4, 2021

Similarly, other companies in the domain such as Eisai/ BioArctic AB, Hoffmann-La Roche/Chugai Pharmaceuticals, Anavex Life Sciences Corp., The companies in the Parkinson’s Disease Therapeutics Market include Cortexyme, Cerevel Therapeutics, Amneal Pharmaceuticals, Pharma Two B, Cerevance, AbbVie, Theranexus, and others.

Marketing 98

Marketing Genetics Development Clinical Development 98

pharmaphorum

DECEMBER 2, 2020

This expertise in fermentation and large-scale pharmaceutical production put Pfizer in good stead when in 1941 the US government appealed to the pharma industry for support in producing penicillin for the war effort. But Pfizer’s almost Hollywood-level blockbuster of the 1990s was the little blue pill of Viagrar. .

Sales 127

Sales Production Drugs Marketing 127

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. But there was some considerable progress in other fields of medicine even though research efforts were diverted away, reports Richard Staines.

Marketing 74

Marketing Gene Silencing Gene Drugs 74

XTalks

MAY 11, 2023

Wendy: RARE-X is now the data and research arm of Global Genes, the flagship patient organization representing rare, ultra-rare, and “n-of-one” patients. That mission is really important to me because I think it’s the only way we’re going to accelerate drug development in rare disease. Development is just the beginning.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

Delveinsight

JULY 29, 2020

Bharat Biotech International Limited (BBIL) is working in collaboration with Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), Pune for COVAXIN which is the first indigenous Covid-19 vaccine candidate in india. Zydus has started the human clinical trials of its plasmid DNA based vaccine, ZyCoV-D.

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

pharmaphorum

OCTOBER 10, 2022

Together, they developed a bold new awareness campaign to help drive awareness of the need for patients at risk of lung cancer to get screened. “We We then worked in partnership to co-create and develop the campaign. The pharma industry has an important role to play in the future of cancer treatment and research.

Development 90

Development Research Marketing Life Science 90

pharmaphorum

OCTOBER 26, 2022

We are working to provide patients, including those living with rare diseases, with safe and effective treatments that improve their quality of life and make these treatments accessible. Every pharma company developing treatments for new diseases is contributing to some degree to better global health. About Chiesi Group.

Development 78

Development Trials Marketing Life Science 78